Lymphoproliferative disease after liver transplantation: primary biliary localization.
Navarro
F
F
Département de Transplantation Hépatique, Hôpital St. Eloi, Montpellier, France.
Pyda
P
P
Pageaux
G P
GP
Perrigault
P F
PF
Ramos
J
J
Taourel
P
P
Fabre
J M
JM
Domergue
J
J
D015703:Antigens, CD / Q000032:analysis; D001402:B-Lymphocytes / Q000276:immunology / Q000473:pathology; D001652:Bile Ducts / Q000276:immunology / Q000473:pathology; D002779:Cholestasis / Q000209:etiology* / Q000276:immunology / Q000601:surgery; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation / Q000276:immunology / Q000473:pathology; D008232:Lymphoproliferative Disorders / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012189:Retrospective Studies
D015703:Antigens, CD; D007166:Immunosuppressive Agents